| Literature DB >> 30349076 |
Lu-Yu Zhou1, Mei Zhai2, Yan Huang2, Sheng Xu1, Tao An2, Yun-Hong Wang2, Rong-Cheng Zhang2, Cui-Yun Liu1, Yan-Han Dong1, Man Wang1, Li-Li Qian1, Murugavel Ponnusamy1, Yu-Hui Zhang2, Jian Zhang2, Kun Wang3.
Abstract
Dysregulated autophagy is associated with many pathological disorders such as cardiovascular diseases. Emerging evidence has suggested that circular RNAs (circRNAs) have important roles in some biological processes. However, it remains unclear whether circRNAs participate in the regulation of autophagy. Here we report that a circRNA, termed autophagy-related circular RNA (ACR), represses autophagy and myocardial infarction by targeting Pink1-mediated phosphorylation of FAM65B. ACR attenuates autophagy and cell death in cardiomyocytes. Moreover, ACR protects the heart from ischemia/reperfusion (I/R) injury and reduces myocardial infarct sizes. We identify Pink1 as an ACR target to mediate the function of ACR in cardiomyocyte autophagy. ACR activates Pink1 expression through directly binding to Dnmt3B and blocking Dnmt3B-mediated DNA methylation of Pink1 promoter. Pink1 suppresses autophagy and Pink1 transgenic mice show reduced myocardial infarction sizes. Further, we find that FAM65B is a downstream target of Pink1 and Pink1 phosphorylates FAM65B at serine 46. Phosphorylated FAM65B inhibits autophagy and cell death in the heart. Our findings reveal a novel role for the circRNA in regulating autophagy and ACR-Pink1-FAM65B axis as a regulator of autophagy in the heart will be potential therapeutic targets in treatment of cardiovascular diseases.Entities:
Mesh:
Substances:
Year: 2018 PMID: 30349076 PMCID: PMC6748144 DOI: 10.1038/s41418-018-0206-4
Source DB: PubMed Journal: Cell Death Differ ISSN: 1350-9047 Impact factor: 15.828